共 50 条
- [31] A cell cycle regulator, transforming acidic coiled-coil protein 2 (TACC2), is an androgen-regulated gene that promotes prostate cancer progressionENDOCRINE JOURNAL, 2010, 57 : S580 - S580Takayama, KenichiSuzuki, TakashiHorie-Inoue, KunikoIkeda, KazuhiroUrano, TomohikoOuchi, YasuyoshiInoue, Satoshi
- [32] 5α-androstane-3α, 17β-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways:: Implication of androgen-independent prostate cancer progressionJOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (05) : 1612 - 1624Yang, QingTitus, Mark A.Fung, Kar-MingLin, Hsueh-Kung
- [33] Bergamottin a CYP3A inhibitor found in grapefruit juice inhibits prostate cancer cell growth by downregulating androgen receptor signaling and promoting G0/G1 cell cycle block and apoptosisPLOS ONE, 2021, 16 (09):Vetrichelvan, OpalinaGorjala, PriyathamGoodman, OscarMitra, Ranjana
- [34] Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer ProgressionPROSTATE, 2017, 77 (03): : 309 - 320Dejima, TakashiImada, KenjiroTakeuchi, ArioShiota, MasakiLeong, JeffreyTombe, TabithaTam, KevinFazli, LadanNaito, SeijiGleave, Martin E.Ong, Christopher J.
- [35] Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machineryOncogene, 2010, 29 : 345 - 355F J Rodríguez-UbrevaA E Cariaga-MartinezM A CortésM Romero-De PablosS RoperoP López-RuizB Colás
- [36] Outcomes in men with metastatic castrate-resistant prostate cancer treated with early platinum-based chemotherapy following an unsatisfactory response to androgen receptor (AR) inhibition as part of the phase II dynamic allocation modular sequential (DynAMo) trial.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)Viscuse, Paul VincentZhang MiaoLiu JingjingTidwell, RebeccaSubudhi, Sumit KumarZurita, Amado J.Corn, Paul G.Tu Shi-MingAraujo, John C.Wang, JenniferEfstathiou, EleniWang JianboPilie, Patrick GlenTroncoso, PatriciaZhang JianhuaLogothetis, ChristopherAparicio, Ana
- [37] Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machineryONCOGENE, 2010, 29 (03) : 345 - 355Rodriguez-Ubreva, F. J.Cariaga-Martinez, A. E.Cortes, M. A.Romero-De Pablos, M.Ropero, S.Lopez-Ruiz, P.Colas, B.
- [38] Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2-M Cell-Cycle ProgressionMOLECULAR CANCER RESEARCH, 2012, 10 (10) : 1343 - 1358Kastner, StefanVoss, TilmanKeuerleber, SimonGloeckel, ChristinaFreissmuth, MichaelSommergruber, Wolfgang
- [39] The BH3-only protein, Noxa, is upregulated by estrogen and promotes cell cycle progression in estrogen receptor-positive breast cancer cellsCANCER RESEARCH, 2012, 72Swetzig, Wendy M.Liu, WenshengMedisetty, RajeshDas, Gokul M.
- [40] Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast CancerCLINICAL CANCER RESEARCH, 2024, 30 (09) : 1889 - 1905Guarducci, CristinaNardone, AgostinaRusso, DouglasNagy, ZsuzsannaHeraud, CapucineGrinshpun, AlbertZhang, QiFreelander, AllegraLeventhal, Mathew JosephFeit, AveryCohen Feit, GabriellaFeiglin, ArielLiu, WeihanHermida-Prado, FranciscoKesten, NikolasMa, WenDe Angelis, CarmineMorlando, AntonioO'Donnell, MadisonNaumenko, SergeyHuang, ShixiaNguyen, Quang-DeHuang, YingMalorni, LucaBergholz, Johann S.Zhao, Jean J.Fraenkel, ErnestLim, ElgeneSchiff, RachelShapiro, Geoffrey I.Jeselsohn, Rinath